Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.
about
Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study.Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.
P2860
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and safety of dabigat ...... g Atrial Fibrillation Project.
@en
type
label
Efficacy and safety of dabigat ...... g Atrial Fibrillation Project.
@en
prefLabel
Efficacy and safety of dabigat ...... g Atrial Fibrillation Project.
@en
P2093
P2860
P356
P1433
P1476
Efficacy and safety of dabigat ...... ng Atrial Fibrillation Project
@en
P2093
Chern-En Chiang
Chu-Pak Lau
Chung-Wah Siu
Esther W Chan
Gregory Y H Lip
Pak-Hei Chan
Wen-Hua Li
P2860
P304
P356
10.1002/CLC.22649
P577
2016-11-28T00:00:00Z